Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 10/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 6/20 | 0.40 |
| ▸ | TGFBR2 | P37173 | 4/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.39 |
| ▸ | RIPK3 | Q9Y572 | 1/20 | 0.39 |
| ▸ | BUB1 | O43683 | 1/20 | 0.38 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25241528 | 1.00 | MAPK14 (0.41) | MAPK14MAPK10TGFBR1TGFBR2CYP3A4 | |
| SCHEMBL30387728 | 0.90 | BUB1 (0.41) | MAPK14MAPK10TGFBR1TGFBR2RIPK3 | |
| SCHEMBL30387491 | 0.90 | TGFBR1 (0.41) | MAPK14MAPK10TGFBR1TGFBR2CYP3A4 | |
| SCHEMBL25224714 | 0.90 | BUB1 (0.41) | MAPK14MAPK10TGFBR1TGFBR2RIPK3 | |
| SCHEMBL25202926 | 0.90 | TGFBR1 (0.41) | MAPK14MAPK10TGFBR1TGFBR2CYP3A4 | |
| SCHEMBL25206334 | 0.88 | MAPK14 (0.45) | MAPK14 | |
| SCHEMBL30387494 | 0.88 | MAPK14 (0.45) | MAPK14 | |
| SCHEMBL25211191 | 0.87 | MAPK14 (0.42) | MAPK14MAPK10TGFBR1TGFBR2RIPK3 | |
| SCHEMBL30387706 | 0.87 | MAPK14 (0.42) | MAPK14MAPK10TGFBR1TGFBR2RIPK3 | |
| SCHEMBL25217236 | 0.87 | TGFBR1 (0.40) | MAPK14MAPK10TGFBR1TGFBR2RIPK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4188928-A1 | SUBSTITUTED 1 H-PYRROLO[3,2-B]PYRIDIN COMPOUNDS AND METHODS OF USE THEREOF | Bayer Aktiengesellschaft (DE) | 2023-06-07 | — | — | EP | disclosed |